240 related articles for article (PubMed ID: 35779354)
1. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry.
Vogel M; Norwig J
J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354
[TBL] [Abstract][Full Text] [Related]
2. A Full Evaporation Static Headspace Gas Chromatography Method with Nitrogen Phosphorous Detection for Ultrasensitive Analysis of Semi-volatile Nitrosamines in Pharmaceutical Products.
Zheng J; Kirkpatrick CL; Lee D; Han X; Martinez AI; Gallagher K; Evans RK; Mudur SV; Liang X; Drake J; Buhler LA; Mowery MD
AAPS J; 2022 Jan; 24(1):23. PubMed ID: 34993666
[TBL] [Abstract][Full Text] [Related]
3. The contamination of valsartan and other sartans, part 1: New findings.
Sörgel F; Kinzig M; Abdel-Tawab M; Bidmon C; Schreiber A; Ermel S; Wohlfart J; Besa A; Scherf-Clavel O; Holzgrabe U
J Pharm Biomed Anal; 2019 Aug; 172():395-405. PubMed ID: 31122801
[TBL] [Abstract][Full Text] [Related]
4. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.
Parr MK; Joseph JF
J Pharm Biomed Anal; 2019 Feb; 164():536-549. PubMed ID: 30458387
[TBL] [Abstract][Full Text] [Related]
5. Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.
Yamamoto E; Kan-No H; Tomita N; Ando D; Miyazaki T; Izutsu KI
J Pharm Biomed Anal; 2022 Feb; 210():114561. PubMed ID: 34974238
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Novel LC-MS/MS Based Analytical Method for the Risk Assessment of Nitrosamines in Pharmaceutical Products and Packaging Materials.
Kartop RA; Güleli M; Faruzlu FA; Çalışkan C
J Pharm Sci; 2024 Jun; 113(6):1597-1606. PubMed ID: 38253223
[TBL] [Abstract][Full Text] [Related]
7. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
Mavis ME; Goksu Gursu G; Ular Cagatay N
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
Kalauz A; Tiringer KV; Horváth V; Kapui I
J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of carcinogenic N-nitrosamine impurities in metformin tablets using on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry.
Ishizaki A; Ozawa K; Kataoka H
J Chromatogr A; 2023 Nov; 1710():464416. PubMed ID: 37804578
[TBL] [Abstract][Full Text] [Related]
10. Determination of eight nitrosamines in water at the ng L(-1) levels by liquid chromatography coupled to atmospheric pressure chemical ionization tandem mass spectrometry.
Ripollés C; Pitarch E; Sancho JV; López FJ; Hernández F
Anal Chim Acta; 2011 Sep; 702(1):62-71. PubMed ID: 21819861
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.
Chang SH; Ho HY; Chang CC; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY
J Pharm Biomed Anal; 2022 Nov; 221():115003. PubMed ID: 36095885
[TBL] [Abstract][Full Text] [Related]
12.
Zmysłowski A; Książek I; Szterk A
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202951
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography.
Schmidtsdorff S; Schmidt AH
J Pharm Biomed Anal; 2019 Sep; 174():151-160. PubMed ID: 31174128
[TBL] [Abstract][Full Text] [Related]
14. Analysis of selected drug formulations for volatile nitrosamines.
Dawson BA; Lawrence RC
J Assoc Off Anal Chem; 1987; 70(3):554-6. PubMed ID: 3610969
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
[TBL] [Abstract][Full Text] [Related]
16. Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS.
Witkowska AB; Giebułtowicz J; Dąbrowska M; Stolarczyk EU
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292981
[TBL] [Abstract][Full Text] [Related]
17. Analysis of N-nitrosamines and N-nitrosatable substances from baby bottle rubber teats by liquid chromatography tandem mass spectrometry.
Hwang JB; Lee JE; Kim E; Eom KY; Kim HA; Lee S
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2023 Apr; 40(4):518-527. PubMed ID: 36972401
[TBL] [Abstract][Full Text] [Related]
18. Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.
Lim HH; Oh YS; Shin HS
J Pharm Biomed Anal; 2020 Sep; 189():113460. PubMed ID: 32663759
[TBL] [Abstract][Full Text] [Related]
19. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.
Yang J; Marzan TA; Ye W; Sommers CD; Rodriguez JD; Keire DA
AAPS J; 2020 Jul; 22(4):89. PubMed ID: 32613429
[TBL] [Abstract][Full Text] [Related]
20. NDMA analytics in metformin products: Comparison of methods and pitfalls.
Fritzsche M; Blom G; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Hickert S; Reifenberg P; Cimelli A; Baranowski R; Desmartin E; Barrau E; Harrison M; Bristow T; O'Neill N; Kirsch A; Krueger P; Saal C; Mouton B; Schlingemann J
Eur J Pharm Sci; 2022 Jan; 168():106026. PubMed ID: 34597792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
